Dr Devjit Srivastava

Co-opted to FPM Board in: 2025

Hospital: Raigmore Hospital, NHS Highland

Register of Interests: 

• Faculty of Pain Medicine: Chair, Education Sub-Committee & Events
• Honorary Senior Lecturer, Population Health & Genomics, University of Dundee
• British Pain Society: Scientific Committee Member
• UK Home Office/ACMD: Co-opted Member, Ketamine Working Group
• Chief/Co-Investigator on: VROOM Trial (Virtual Reality for perioperative anxiety and pain-IRAS ID: 339185) and EnLighten trial on IV Lidocaine.
• Visiting/Private Practice: Albyn Hospital, Inverness/Aberdeen
• Director, Delphi Medical Services Ltd (provider of independent pain medicine and medico-legal services)
• Co-inventor of a 2025 U.S. patent titled “Gene therapy of the FAAH pseudogene” (US 12241066). Declared for transparency; no current commercial exploitation.